New Key Statistics Module, Z-Score and F-Score
NAS:KPTI Key Ratios
| Market Cap $ M | 123.45 |
| Enterprise Value $ M | 109.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 146.00 |
| EPS (TTM) $ | -1.25 |
| Beneish M-Score | -2.9 |
| 10-y EBITDA Growth Rate % | 11.20 |
| 5-y EBITDA Growth Rate % | 19.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.92 |
| EV-to-EBITDA | -0.92 |
| PEG | -- |
| Shares Outstanding M | 116.47 |
| Net Margin (%) | -97.99 |
| Operating Margin % | -88.71 |
| Pre-tax Margin (%) | -97.77 |
| Quick Ratio | 3.32 |
| Current Ratio | 3.37 |
| ROA % (ttm) | -47.95 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -631.41 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.67 |
KPTI Number of Guru Trades
KPTI Volume of Guru Trades
Gurus Latest Trades with NAS:KPTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KPTI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Karyopharm Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KPTI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers